T-Cell Lymphoma Clinical Trials

A listing of T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
BI-1808 as a Single Agent and With Pembrolizumab in Treatment of Advanced Malignancies

iRECIST can be applied for efficacy assessment) and subjects with cutaneous T-cell lymphoma (CTCL), specifically Szary Syndrome (SS) and mycosis fungoides (MF). The study will consist of 2 phases

  • 0 views
  • 21 Jun, 2021
  • 8 locations
IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

This is an open label, multi-cohort, and multi-center phase II study, which evaluates the clinical activity and safety of IPH4102 in Sezary Syndrome and Mycosis fungoides as single agent.

peripheral t-cell lymphoma
lymphoma
large cell lymphoma
neutrophil count
fungal infection
  • 26 views
  • 12 Jun, 2021
  • 45 locations
Study of Tinostamustine First-in-Class Alkylating HDACi Fusion Molecule in Relapsed/Refractory Hematologic Malignancies

This study evaluates the efficacy, safety and pharmacokinetics of tinostamustine (EDO-S101) in patients with relapsed/refractory hematologic malignancies. All patients will receive tinostamustine.

peripheral t-cell lymphoma
lymphoma
leukemia
refractory multiple myeloma
neutrophil count
  • 0 views
  • 14 Jun, 2021
  • 26 locations
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

This trial will look at a drug called SEA-TGT (also known as SGN-TGT) to find out whether it is safe for patients with solid tumors and lymphomas. It will study SEA-TGT to find out what its side effects are. A side effect is anything the drug does besides treating cancer. …

positron emission tomography
lymphoma
erbb2
cyclophosphamide
stage iv non-small cell lung cancer
  • 2 views
  • 22 Jun, 2021
  • 11 locations
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

transplant may result in fewer problems and side effects. Eligibility Recipients: People ages 12 and older with peripheral T cell lymphoma that does not respond to

cell transplantation
lymphoma
blood transfusion
hla typing
hemophagocytic lymphohistiocytosis
  • 3 views
  • 24 Jun, 2021
  • 2 locations
A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma

+oxaliplatin]), after treatments of 2 to 6 cycles transferring to ATG-010 monotherapy maintenance treatment, to evaluate the safety, tolerability, and primary efficacy of ATG-010 in R/R PTCL and NK/T-cell

  • 0 views
  • 23 Jun, 2021
  • 5 locations
A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)

This study will include patients with mature T-cell lymphoma (MTCL) that has been treated with at least one type of chemotherapy, but is not responding or coming back after the previous

cell transplantation
peripheral t-cell lymphoma
leukemia
lymphoma
avid
  • 23 views
  • 13 Jun, 2021
  • 6 locations
A Phase 1 Study of Romidepsin CC-486 (5-azacitidine) Dexamethasone and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

-positive cutaneous T-cell lymphoma Age greater than or equal to 18 years of age ECOG performance status of less than or equal to 2 (or less than or equal to 3 if decrease is due to

lymphoma
leukemia
neutrophil count
cyclophosphamide
doxorubicin
  • 0 views
  • 12 Jun, 2021
  • 1 location
Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell and Indolent B-Cell Lymphomas

The investigators hypothesize that duvelisib maintenance after autologous stem cell transplant with carmustine, etoposide, cytarabine, and melphalan (BEAM) conditioning in patients with T-cell lymphomas, or a history of indolent B-cell lymphomas, will be safe and well tolerated, and will improve progression free survival.

cell transplantation
peripheral t-cell lymphoma
large cell lymphoma
melphalan
neutrophil count
  • 0 views
  • 23 Jun, 2021
  • 1 location
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma

The purpose of this trial is to assess the efficacy of E7777 in participants with recurrent or persistent Cutaneous T-Cell Lymphoma (CTCL) in Stage I - III participants as assessed by objective

  • 181 views
  • 22 Jun, 2021
  • 23 locations